MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer

NKG2D (natural killer group 2, member D) is thought to play an important role in mediating the activation of anticancer immune response. Expression of NKG2D ligands (NKG2DLs) is pronounced in malignancies and the heterogeneity of NKG2DL expression remains unclear.